Our Research

An integrated computational and experimental approach to improve phage therapy design.

Motivation: the AMR challenge

Antimicrobial resistance is a growing global health threat. As antibiotics lose effectiveness, there is urgent need for therapies that can target resistant bacteria with greater precision. Bacteriophages are promising because they naturally infect bacteria and can be selected for narrow, intentional targeting.

However, clinical use is still constrained by a major bottleneck: quickly identifying phages that will effectively lyse a specific patient isolate. This matching process is often labor intensive and time sensitive.

What Team BATTLE is building

1) LLM-supported phage generation

Investigate whether genome-scale language modeling can help generate viable candidate phages with lytic characteristics.

2) Phage-host scoring

Develop models that predict infectivity likelihood using genomic and protein-level features from both phage and host.

3) Interaction simulation

Model infection dynamics over time to estimate treatment-relevant outcomes such as kill curves and resistance behavior.

4) Closed-loop validation

Use plaque assays, titer measurements, and growth/lysis experiments to validate and continuously refine model predictions.

Research goals

  • Improve predictive accuracy for phage infectivity against Staphylococcus aureus strains.
  • Move beyond genus-level matching toward more treatment-relevant quantitative predictions.
  • Incorporate biological realism into model features, including resistance and defense-system considerations.
  • Build a practical computational backbone that reduces expensive trial-and-error wet-lab screening.

Research pipeline overview

BATTLE research infographic showing integrated computational and experimental workflow